| |
|
Form Serial Number: |
DA20221214E00352
|
| 1.
Date of relevant event: |
05/07/2022
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
01877 |
| 4.
Name of listed corporation: |
Shanghai Junshi Biosciences Co., Ltd. - H Shares |
| 5.
Class of shares: |
A Shares |
| 6.
Number of issued shares in class: |
693,306,200 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
TANG |
| (Other names) |
YI |
|
|
|
| 10.
Name of director (Chinese): |
湯毅 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1711 | Miscellaneous
Other (you must briefly describe the relevant event in the Supplementary Information box) |
|
| 2501 | Other (you must describe the capacity in the Supplementary Information box) |
|
| 2501 | Other (you must describe the capacity in the Supplementary Information box) |
|
|
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 204,646,286 | 29.60 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 204,646,286 | 29.52 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| |
| 2201 | Interest of corporation controlled by you |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| Long position | | 4105 | Unlisted derivatives - Physically settled |
| 16/11/2021 | | | | | | | | 328,000 |
| Long position | | 4105 | Unlisted derivatives - Physically settled |
| 16/11/2022 | 15/11/2023 | | | | | | | 246,000 |
| Long position | | 4105 | Unlisted derivatives - Physically settled |
| 16/11/2023 | 15/11/2024 | | | | | | | 246,000 |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| 深圳前海源本股权投资基金管理有限公司 | 中国广东省深圳市前海深港合作区前湾一路鲤鱼门街1号前海深港合作管理局综合办公楼A栋201室 (中国) | Tang Yi | 60.00 | N | |
| 苏州本裕天源生物科技合伙企业(有限合伙) | 中国江苏省苏州工业园区唯正路8号 (中国) | 深圳前海源本股权投资基金管理有限公司 | 86.28 | Y | |
| 苏州本裕天源生物科技合伙企业(有限合伙) | 中国江苏省苏州工业园区唯正路8号 (中国) | 深圳前海源本股权投资基金管理有限公司 | 86.28 | N | |
| 苏州瑞源盛本生物医药管理合伙企业(有限合伙) | 中国江苏省苏州市吴江区松陵镇开发区云黎路北侧 (中国) | 深圳前海源本股权投资基金管理有限公司 | 39.52 | Y | |
| 苏州瑞源盛本生物医药管理合伙企业(有限合伙) | 中国江苏省苏州市吴江区松陵镇开发区云黎路北侧 (中国) | 深圳前海源本股权投资基金管理有限公司 | 39.52 | N | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| | | |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
On 05 July 2022, the Company issued 1,845,200 new A shares pursuant to the exercise of pre-IPO share options granted under the Pre-IPO Share Incentive Scheme. As a result, the percentage level of TANG Yi's interest in the Company's A Shares has reduced. Box 28: The end date of the exercise period of the 328,000 shares interested through derivatives is 15/11/2022.
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 3A: |
14/12/2022
(dd/mm/yyyy)
|
| |